ZANGRILLI, ARIANNA

ZANGRILLI, ARIANNA  

ex-Dipartimento di Medicina Interna  

Mostra records
Risultati 1 - 20 di 30 (tempo di esecuzione: 0.038 secondi).
Data di pubblicazione Titolo Autore(i) Tipo File
1-gen-2008 Adalimumab for moderate to severe psoriasis: an open-label, retrospective 3-year study Papoutsaki, M; Chimenti, Ms; Talamonti, M; Zangrilli, A; Teoli, M; Kroegler, B; Perricone, R; Chimenti, S Intervento a convegno
1-gen-2007 Adalimumab for severe psoriasis and psoriatic arthritis: an open-label study in 30 patients previously treated with other biologics Papoutsaki, M; Chimenti, Ms; Costanzo, A; Talamonti, M; Zangrilli, A; Giunta, A; Bianchi, L; Chimenti, S Articolo su rivista
6-apr-2020 Adalimumab in children and adolescents with severe plaque psoriasis: a safety evaluation Zangrilli, A; Bavetta, M; Bianchi, L Articolo su rivista
3-ott-2019 Adalimumab in severe plaque psoriasis of childhood: A multi-center, retrospective real-life study up to 52 weeks observation Lernia, Vd; Bianchi, L; Guerriero, C; Stingeni, L; Gisondi, P; Filoni, A; Guarneri, C; Belloni Fortina, A; Lasagni, C; Simonetti, O; Neri, I; Zangrilli, A; Moretta, G; Hansel, K; Casanova, Dm; Girolomoni, G; Cannavò, Sp; Bonamonte, D Articolo su rivista
1-gen-2013 Adalimumab in the treatment of plaque-type psoriasis and psoriatic arthritis Saraceno, R; Bavetta, M; Zangrilli, A; Chiricozzi, A; Potenza, C; Chimenti, S; Chimenti, Ms Articolo su rivista
1-gen-2005 Clinical severity instruments Zangrilli, A; Talamonti, M; Saraceno, R; Chimenti, S Contributo in libro
1-nov-2014 Detection of adalimumab and anti-adalimumab levels by ELISA: clinical considerations Marinari, B; Botti, E; Bavetta, M; Spallone, G; Zangrilli, A; Talamonti, M; Richetta, A; Chimenti, S; Costanzo, A Articolo su rivista
1-gen-2019 Efficacy and safety of adalimumab after failure of other anti-TNFα agents for plaque-type psoriasis: clinician behavior in real life clinical practice Esposito, M; Prignano, F; Rongioletti, F; Hansel, K; Bianchi, L; Pescitelli, L; Lazzeri, L; Ricceri, F; Mugheddu, C; Bavetta, M; Zangrilli, A; Bianchi, L; Bini, V; Stingeni, L Articolo su rivista
1-gen-2020 Efficacy and safety of Adalimumab in difficult-to-treat psoriasis Lanna, C; Zangrilli, A; Bavetta, M; Campione, E; Bianchi, L Articolo su rivista
1-gen-2013 Efficacy and Safety of Subcutaneous Anti-Tumor Necrosis Factor-Alpha Agents, Etanercept and Adalimumab, in Elderly Patients Affected by Psoriasis and Psoriatic Arthritis: An Observational Long-Term Study Esposito, M; Giunta, A; Mazzotta, A; Zangrilli, A; Babino, G; Bavetta, M; Perricone, R; Chimenti, S; Chimenti, Ms Articolo su rivista
1-gen-2007 Erysipeloid cutaneous metastasis from bladder carcinoma Zangrilli, A; Saraceno, R; Sarmati, L; Orlandi, A; Bianchi, L; Chimenti, S Articolo su rivista
1-gen-2017 HLA-C*06:02 Does Not Predispose to Clinical Response Following Long-Term Adalimumab Treatment in Psoriatic Patients: A Retrospective Cohort Study. Talamonti, M; Galluzzo, M; Zangrilli, A; Papoutsaki, M; Egan, C; Bavetta, M; Tambone, S; Fargnoli, M; Bianchi, L Articolo su rivista
18-giu-2020 Ixekizumab: One drug for an enigmatic psoriasis Piccolo, A; Pensa, C; Zangrilli, A; Bavetta, M; Orlandi, A; Bianchi, L Articolo su rivista
11-nov-2020 A linear forehead lesion caused by intralesional injection of triamcinolone acetonide and treated with hyaluronic acid filler: case report Piccolo, A; Pensa, C; Zangrilli, A; Bavetta, M; Diluvio, L; Bianchi, L Articolo su rivista
1-gen-2008 Long-term efficacy of adalimumab in generalized pustular psoriasis Zangrilli, A; Papoutsaki, M; Talamonti, M; Chimenti, S Articolo su rivista
1-gen-2018 Long-term treatment of psoriatic patients with adalimumab reduces disease severity and maintains a favorable lipid pattern and a low Atherogenic Index. Zangrilli, A; Bavetta, M; Scaramella, M; Bianchi, L Articolo su rivista
20-ott-2020 A multicenter study on effectiveness and safety of risankizumab in psoriasis: an Italian 16-week real-life experience during the COVID-19 pandemic Hansel, K; Zangrilli, A; Bianchi, L; Peris, K; Chiricozzi, A; Offidani, A; Diotallevi, F; Fargnoli, Mc; Esposito, M; Amerio, P; Gualdi, G; Bianchi, L; Stingeni, L Articolo su rivista
1-gen-2020 Omalizumab and adalimumab: a winning couple Diluvio, L; Vollono, L; Zangrilli, A; Manfreda, V; Prete, Md; Massaro, A; Modica, S; Greco, E; Bianchi, L; Campione, E Articolo su rivista
1-gen-2019 One drug and two diseases: A case of multidrug-resistant hidradenitis suppurativa and psoriasis treated with apremilast Lanna, C; Mazzilli, S; Zangrilli, A; Bianchi, L; Campione, E Articolo su rivista
1-gen-2018 Paradoxical case effects of psoriasis following adalimumab therapy: A case series Zangrilli, A; Bavetta, M; Mazzilli, S; Garofalo, V; Bianchi, L Articolo su rivista